Page last updated: 2024-09-05

sorafenib and betulin

sorafenib has been researched along with betulin in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (betulin)	Trials (betulin)	Recent Studies (post-2010) (betulin)
6,520	730	5,251	422	8	287

Protein Interaction Comparison

Protein	Taxonomy	sorafenib (IC50)	betulin (IC50)
Transcription factor p65	Homo sapiens (human)		8.8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, Y; Feng, F; Li, Z; Wang, L; Wang, X; Yin, F	1

Other Studies

1 other study(ies) available for sorafenib and betulin

Article	Year
SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity. Cell death & disease, 2019, 09-11, Volume: 10, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glycolysis; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Mice; Mice, Nude; Prognosis; Sorafenib; Sterol Regulatory Element Binding Protein 1; Transplantation, Heterologous; Triterpenes	2019

Article

Year

SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.

Cell death & disease, 2019, 09-11, Volume: 10, Issue:9

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glycolysis; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Mice; Mice, Nude; Prognosis; Sorafenib; Sterol Regulatory Element Binding Protein 1; Transplantation, Heterologous; Triterpenes

2019